-
The inequity in the allocation of pharmaceutical products across regions or populations leading to disparity in access to essential medications. Often driven by socioeconomic, logistical, or geographic factors, this inequality results in some communities facing shortages while others experience surplus.
-
The insufficient availability of essential medicines and pharmaceutical products to meet demand often caused by disruptions in production, supply chain inefficiencies, regulatory issues, or sudden spikes in demand.
Click on the continents displayed on the global map to view their pharmaceutical Surplus (Blue) and Shortage (Red) levels. This interactive feature lets you explore and compare surplus data for each continent in real-time.
-
The accumulation of excess pharmaceutical products that exceed demand often due to overproduction, inaccurate forecasting, or inefficient distribution.
-
The discarded or unused pharmaceutical products, including expired medications, damaged stock, and excess drugs from overproduction, oversupply, or improper inventory management.